Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1476 of 5804
-
Mouthwash test may spot hidden throat cancer
Diagnosis CompletedThe purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Ultrasound opens brain barrier to deliver Parkinson's drug in first human test
Disease control Recruiting nowThe goal of this study is to establish safety and feasibility of intracerebral delivery of GCase via MRgFUS. This technique may offer potential benefits given the exposure of the putamen to GCase in animal models has been shown to be efficacious in improving Parkinson's disease p…
Phase: NA • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New pill combo takes on Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two parts: PF-07799544 as a single agent (Phase …
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Text and phone support helps cervical cancer survivors kick the habit
Disease control OngoingThe goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for rare disease: experimental drug targets PMM2-CDG
Disease control CompletedThis is a Phase 2, randomized, open-label, 24-week treatment study to evaluate the potential pharmacodynamic (PD) activity, safety, tolerability, and pharmacokinetics (PK) of GLM101 in adult, adolescent, and pediatric, patients with a confirmed diagnosis of PMM2-CDG. The planned …
Phase: PHASE2 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a new pill boost brain function in early Alzheimer's?
Symptom relief CompletedThe primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:13 UTC
-
New dialysis graft aims to reduce blockages and infections
Disease control OngoingThis study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft-3 hemodialysis access graft. STARgraft devices have been demonstrated in preclinical and other studies to have improved resistance to the common failure mod…
Phase: NA • Sponsor: Healionics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Diet and supplements tested to stop blood cancer before it starts
Prevention Recruiting nowThe researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM)…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Massive study aims to unlock cancer secrets in african ancestry
Knowledge-focused Recruiting nowThe goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of African ancestry. The study is conducted by the African Caribbean Cancer Consortium (AC3) and involves the recruitment of patient…
Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New RA strategy: switch drugs after 12 weeks for better control?
Disease control Recruiting nowIn rheumatoid arthritis (RA), the consensual 1st line conventional synthetic disease modifying antirheumatic drugs (csDMARD) of RA is methotrexate (MTX). In case of contra-indication or intolerance to MTX, leflunomide is an alternative. If the treatment target is not achieved wit…
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New antibody IMT-009 tested in patients with advanced cancers
Disease control OngoingThis is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with solid tumors or lymphomas. The main goals of this study are to: * Find the recommended dose of IMT-009…
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Sound waves and clot-busters: a new hope for PE survivors?
Disease control Recruiting nowThe purpose of this retrospective and prospective multicenter study is to evaluate the incidence of pulmonary hypertension (PH) within 6 months from ultrasound-assisted, Catheter-directed Thrombolysis for acute intermediate- high-risk Pulmonary Embolism
Sponsor: Niguarda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New IV iron shot aims to boost low blood counts in kids who can't take pills
Disease control Recruiting nowSeveral clinical trials have been reported for ferric derisomaltose where it has been shown to be well tolerated and to improve markers of IDA. All clinical trials with ferric derisomaltose have been performed in adults, however, IDA is not specific to the adult population. In fa…
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill could tame stubborn ulcerative colitis
Disease control OngoingThis is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for further clinical development will be ba…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for tough liver cancers? early trial tests Two-Drug punch
Disease control OngoingTo evaluate the efficacy and safety of Cadonilimab Injection in combination with Regorafenib in the treatment of intermediate to advanced hepatocellular carcinoma that has failed at least one prior systemic therapy .
Phase: PHASE1 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New universal cell therapy shows promise for Hard-to-Treat blood cancer
Disease control TerminatedA Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Universal BCMA-targeted LUCAR-B68 Cells Product in Patients With Relapsed/Refractory Multiple Myeloma
Phase: PHASE1 • Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets genetic weakness in advanced breast cancer
Disease control TerminatedThis study is planned to include 80 patients with HRD positive HER2-negative advanced breast cancer to receive fluzoparib alone or fluzoparib combined with camrelizumab to observe and evaluate the efficacy and safety of fluzoparib combined with or without camrelizumab in the trea…
Phase: PHASE2 • Sponsor: wang shusen • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Phone app aims to lift depression and boost HIV treatment in teens
Disease control OngoingThe overall goal of this study is to develop an mHealth intervention (Suubi-Mhealth) for use among Ugandan youth (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. This digital therapy intervention deliv…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control OngoingThis clinical trial evaluates the safety and effectiveness of adding itacitinib to cyclophosphamide and tacrolimus for the prevention of graft versus host disease (GVHD) in patients undergoing hematopoietic stem cell transplant. Itacitinib is an enzyme inhibitor that may regulate…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to slow lung scarring in hypersensitivity pneumonitis
Disease control OngoingTo our knowledge, there is no randomized controlled trial assessing the efficacy of mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a regimen consist…
Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC